203895 Sigma-AldrichBTS - CAS 1576-37-0 - Calbiochem
A potent inhibitor of Ca2+-stimulated myosin S1 ATPase (IC₅₀ = ~ 5 µM) and reversibly blocks the gliding motility.
More>> A potent inhibitor of Ca2+-stimulated myosin S1 ATPase (IC₅₀ = ~ 5 µM) and reversibly blocks the gliding motility. Less<<BTS - CAS 1576-37-0 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
同义词: N-Benzyl-p-toluenesulphonamide
Recommended Products
概述
| Replacement Information |
|---|
重要规格表
| CAS # | Empirical Formula |
|---|---|
| 1576-37-0 | C₁₄H₁₅NO₂S |
Products
| 产品目录编号 | 包装 | 数量 / 包装 | |
|---|---|---|---|
| 203895-5MGCN | 塑胶安瓿;塑胶针药瓶 | 5 mg |
| References | |
|---|---|
| References | Cheung, A., et al. 2002. Nat. Cell Biol. 4, 83. |
| Product Information | |
|---|---|
| CAS number | 1576-37-0 |
| ATP Competitive | N |
| Form | White crystalline solid |
| Hill Formula | C₁₄H₁₅NO₂S |
| Chemical formula | C₁₄H₁₅NO₂S |
| Reversible | Y |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | Ca2+-stimulated myosin S1 ATPase |
| Primary Target IC<sub>50</sub> | ~5 µM against Ca2+-stimulated myosin S1 ATPase |
| Purity | ≥95% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | N |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS | |
|---|---|
| RTECS | XT5490000 |
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| 产品目录编号 | GTIN |
| 203895-5MGCN | 04055977219920 |
Documentation
BTS - CAS 1576-37-0 - Calbiochem MSDS
| 职位 |
|---|
BTS - CAS 1576-37-0 - Calbiochem 分析证书
| 标题 | 批号 |
|---|---|
| 203895 |
参考
| 参考信息概述 |
|---|
| Cheung, A., et al. 2002. Nat. Cell Biol. 4, 83. |



